Hurdles in anticancer drug development from a regulatory perspective
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://www.nature.com/articles/nrclinonc.2012.14.pdf
Reference54 articles.
1. Arteaga, C. L. et al. Treatment of HER2-positive breast cancer: current status and future perspectives. Nat. Rev. Clin. Oncol. 9, 16–32 (2012).
2. Quintás-Cardama, A., Kantarjian, H. & Cortes, J. Imatinib and beyond—exploring the full potential of targeted therapy for CML. Nat. Rev. Clin. Oncol. 6, 535–543 (2009).
3. Sleijfer, S., Wiemer, E. & Verweij, J. Drug Insight: gastrointestinal stromal tumors (GIST)—the solid tumor model for cancer-specific treatment. Nat. Clin. Pract. Oncol. 5, 102–111 (2008).
4. Ravaud, A. et al. Update on the medical treatment of metastatic renal cell carcinoma. Eur. Urol. 54, 315–325 (2008).
5. Apolone, G., Tafuri, G., Trotta, F. & Garattini S. A new anti-cancer drug in the market: Good news for investors or for patients? Eur. J. Cancer 44, 1786–1788 (2008).
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. l‐Asparaginase Bio‐Betters: Insight Into Current Formulations, Optimization Strategies and Future Bioengineering Frontiers in Anti‐Cancer Drug Development;Advanced Therapeutics;2024-08-19
2. Drug Lag and Associated Factors for Approved Drugs in Korea Compared with the United States;International Journal of Environmental Research and Public Health;2022-03-01
3. Tumor microenvironment targeting with dual stimuli-responsive nanoparticles based on small heat shock proteins for antitumor drug delivery;Acta Biomaterialia;2020-09
4. Prediction of Drug Approval After Phase I Clinical Trials in Oncology: RESOLVED2;JCO Clinical Cancer Informatics;2019-12
5. An anti-cancerous protein fraction from Withania somnifera induces ROS-dependent mitochondria-mediated apoptosis in human MDA-MB-231 breast cancer cells;International Journal of Biological Macromolecules;2019-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3